Keywords: UK, NICE, PharmaMr, Zeltia, Yondelis, GlaxoSmithKline, Arzerra

UK’s NICE turns down PharmaMar’s Yondelis and GlaxoSmithKline’s Arzerra

Article | 20 September 2010

Print This

The UK’s National Institute for Health and Clinical Excellence (NICE) gave another couple of negative opinions for use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in